Stockscreener 앱 받기
42.97
8.07%
-3.77
시간 외 거래:
42.12
-0.85
-1.98%
전일 마감가:
$46.74
열려 있는:
$46.8
하루 거래량:
396.48K
Relative Volume:
1.97
시가총액:
$403.53M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-4.24
EPS:
-10.1344
순현금흐름:
$-82.84M
1주 성능:
-7.03%
1개월 성능:
+21.01%
6개월 성능:
+231.30%
1년 성능:
+17.56%
1일 변동 폭
$40.70
$46.80
1주일 범위
$40.70
$50.64
52주 변동 폭
$10.29
$98.00
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
KRRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
42.97 | 438.93M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Has Korro Bio Inc. formed a bullish divergence2025 Earnings Impact & Community Verified Swing Trade Signals - newser.com
Short interest data insights for Korro Bio Inc.Weekly Stock Recap & High Accuracy Trade Alerts - newser.com
Using economic indicators to assess Korro Bio Inc. potential2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
Using Python tools to backtest Korro Bio Inc. strategiesDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Tools to assess Korro Bio Inc.’s risk profile2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Is a relief rally coming for Korro Bio Inc. holdersEarnings Growth Summary & Short-Term High Return Strategies - newser.com
Korro Bio, Inc. Announces Chief Financial Officer Changes, Effective October 17, 2025 - MarketScreener
Korro Bio CFO Vineet Agarwal to step down, CEO Ram Aiyar named interim CFO - Investing.com Canada
Korro BioVineet Agarwal announces intention to resign from his position of CFO - MarketScreener
What analysts say about Korro Bio Inc stockEarnings Growth Patterns & Free Double Digit Growth Tips - earlytimes.in
What drives Korro Bio Inc stock priceValue Traps to Avoid & Free High Yield Investment Strategies - earlytimes.in
Live market analysis of Korro Bio Inc.Market Growth Summary & Short-Term Trading Opportunity Alerts - newser.com
Chart based analysis of Korro Bio Inc. trends2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Is Korro Bio Inc. stock reversal real or fake2025 Year in Review & Momentum Based Trading Ideas - newser.com
Korro Bio Inc. stock prediction for this weekWeekly Stock Analysis & Free Community Supported Trade Ideas - newser.com
When is the best time to exit Korro Bio Inc.Day Trade & AI Forecasted Entry/Exit Points - newser.com
Press Release: Korro Reports Full Year 2024 Financial Results and Provides Business Updates - 富途牛牛
Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $180 - 富途牛牛
Applying sector rotation models to Korro Bio Inc.Market Growth Report & Safe Capital Growth Tips - newser.com
How to build a custom watchlist for Korro Bio Inc.2025 Investor Takeaways & Community Consensus Picks - newser.com
Key metrics from Korro Bio Inc.’s quarterly dataQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
Korro Bio Inc. stock retracement – recovery analysisWeekly Trade Report & Community Shared Stock Ideas - newser.com
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Korro Bio Inc 주식 (KRRO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
5.74%
자본화:
|
볼륨(24시간):